A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism

被引:6
|
作者
Apaolaza, Inigo [1 ,2 ,3 ]
San Jose-Eneriz, Edurne [4 ,5 ,6 ]
Valcarcel, Luis V. [1 ,4 ,5 ]
Agirre, Xabier [4 ,5 ,6 ]
Prosper, Felipe [4 ,5 ,6 ,7 ]
Planes, Francisco J. [1 ,2 ,3 ]
机构
[1] Univ Navarra, Tecnun Escuela Ingn, San Sebastian, Spain
[2] Univ Navarra, Ctr Ingn Biomed, Pamplona, Spain
[3] Univ Navarra, DATAI Inst Ciencia Datos & Inteligencia Artificia, Pamplona, Spain
[4] Univ Navarra, CIMA Ctr Invest Med Aplicada, Pamplona, Spain
[5] IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain
[6] CIBERONC Ctr Invest Biomed Red Canc, Pamplona, Spain
[7] Clin Univ Navarra, Pamplona, Spain
关键词
CELLS; REQUIREMENTS;
D O I
10.1371/journal.pcbi.1009395
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies. Author summary Metabolic reprogramming is one of the hallmarks of tumor cells. Synthetic lethality (SL) is a promising approach to exploit these metabolic alterations and elucidate cancer-specific genetic dependences. However, current SL approaches do not systematically consider tumor microenvironment, which is particularly important in cancer metabolism in order to generalize identified genetic dependences. In this article, we directly address this issue and propose a more general approach to SL that integrates both genetic and environmental context of tumor cells. Our definition can help to contextualize genetic dependencies in different environmental scenarios, but it could also reveal nutrient dependencies according to the genetic context. We also provide a computational pipeline to identify this new family of synthetic lethals in genome-scale metabolic networks. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of cancer cell lines, elucidating cholesterol and myo-Inositol depletion as potential vulnerabilities in different malignancies.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Biomarker prediction in autism spectrum disorder using a network-based approach
    Maryam Rastegari
    Najmeh Salehi
    Fatemeh Zare-Mirakabad
    BMC Medical Genomics, 16
  • [32] Multi-view graph convolutional network for cancer cell-specific synthetic lethality prediction
    Fan, Kunjie
    Tang, Shan
    Gokbag, Birkan
    Cheng, Lijun
    Li, Lang
    FRONTIERS IN GENETICS, 2023, 13
  • [33] Prediction of Cancer-Related piRNAs Based on Network-Based Stratification Analysis
    Liu, Yajun
    Xie, Guo
    Li, Aimin
    He, Zongzhen
    Hei, Xinhong
    INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE, 2022, 36 (01)
  • [34] Network-based prediction of drug combinations
    Cheng, Feixiong
    Kovacs, Istvan A.
    Barabasi, Albert-Laszlo
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [35] Network-based prediction of protein interactions
    Kovacs, Istvan A.
    Luck, Katja
    Spirohn, Kerstin
    Wang, Yang
    Pollis, Carl
    Schlabach, Sadie
    Bian, Wenting
    Kim, Dae-Kyum
    Kishore, Nishka
    Hao, Tong
    Calderwood, Michael A.
    Vidal, Marc
    Barabasi, Albert-Laszlo
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [36] Network-based drug sensitivity prediction
    Ahmed, Khandakar Tanvir
    Park, Sunho
    Jiang, Qibing
    Yeu, Yunku
    Hwang, TaeHyun
    Zhang, Wei
    BMC MEDICAL GENOMICS, 2020, 13 (Suppl 11)
  • [37] Network-based prediction of protein function
    Sharan, Roded
    Ulitsky, Igor
    Shamir, Ron
    MOLECULAR SYSTEMS BIOLOGY, 2007, 3 (1) : 1 - 13
  • [38] Network-based prediction of protein interactions
    István A. Kovács
    Katja Luck
    Kerstin Spirohn
    Yang Wang
    Carl Pollis
    Sadie Schlabach
    Wenting Bian
    Dae-Kyum Kim
    Nishka Kishore
    Tong Hao
    Michael A. Calderwood
    Marc Vidal
    Albert-László Barabási
    Nature Communications, 10
  • [39] Network-based prediction of drug combinations
    Feixiong Cheng
    István A. Kovács
    Albert-László Barabási
    Nature Communications, 10
  • [40] Network-based drug sensitivity prediction
    Khandakar Tanvir Ahmed
    Sunho Park
    Qibing Jiang
    Yunku Yeu
    TaeHyun Hwang
    Wei Zhang
    BMC Medical Genomics, 13